Abstract

This study compared the anti-proliferative and apoptotic effects of organic and non-organic Sabah tea on cancer cell lines. Anti-proliferative assays showed that the tea extracts were capable of inhibiting the growth of MCF-7 and HeLa cells. The IC50 values for MCF-7 and HeLa were 20.9 ± 2.6 to 39.3 ± 0.8 and 38.5 ± 3.8 to 42.0 ± 2.3 μg/mL, respectively. Statistical differences were observed in MCF-7 cells treated with organic and non-organic tea extracts. However, no differences were found in HeLa cells. Morphological changes were observed in both treated cell lines when compared with the untreated cells. However, the formation of DNA laddering was only observed in the treated MCF-7 cells. Reduction of BCL-2 expression was found in the treated MCF-7 cells but BAX expression was unaltered. In conclusion, the effect of different farming systems on the proliferation of cancer cells could be cell-type-dependent but they showed no obvious differences in their effects on preventing cancer cell growth and inducing apoptosis. Practical Applications Tea is well known for its various health benefits due to its bioactivity. The findings from this study will add valuable preliminary information regarding the potential of organic and non-organic tea as natural chemopreventive and chemotherapeutic agents. These findings will provide scientific evidence on health advantages that might result from organic food consumption; thus, consumers will be able to make more informed choices.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.